brexucabtagene autoleucel · Medicine question

Which adults with B-cell precursor acute lymphoblastic leukaemia are eligible for Tecartus (brexucabtagene autoleucel)?

Name: Which adults with B-cell precursor acute lymphoblastic leukaemia are eligible for Tecartus (brexucabtagene autoleucel)?
Published: 2026-11-08T01:39:01.551Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Tecartus (brexucabtagene autoleucel) is indicated for adults aged 26 years and above with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia.

Sources for this answer

TecartusGilead Sciences Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 16Document updated 15 May 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about brexucabtagene autoleucel